252 related articles for article (PubMed ID: 30291567)
21. Initiation of antiretroviral therapy after the critical neuronal developmental period of the second postnatal year affects white matter microstructure in adolescents living with HIV.
Hoare J; Heany SJ; Fouche JP; Phillips N; Joska JA; Myer L; Zar HJ; Stein DJ
J Neurovirol; 2019 Apr; 25(2):254-262. PubMed ID: 30617850
[TBL] [Abstract][Full Text] [Related]
22. Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand.
Heaps JM; Sithinamsuwan P; Paul R; Lerdlum S; Pothisri M; Clifford D; Tipsuk S; Catella S; Busovaca E; Fletcher JL; Raudabaugh B; Ratto-Kim S; Valcour V; Ananworanich J;
J Neurovirol; 2015 Apr; 21(2):105-12. PubMed ID: 25604494
[TBL] [Abstract][Full Text] [Related]
23. Clinical factors related to brain structure in HIV: the CHARTER study.
Jernigan TL; Archibald SL; Fennema-Notestine C; Taylor MJ; Theilmann RJ; Julaton MD; Notestine RJ; Wolfson T; Letendre SL; Ellis RJ; Heaton RK; Gamst AC; Franklin DR; Clifford DB; Collier AC; Gelman BB; Marra C; McArthur JC; McCutchan JA; Morgello S; Simpson DM; Grant I;
J Neurovirol; 2011 Jun; 17(3):248-57. PubMed ID: 21544705
[TBL] [Abstract][Full Text] [Related]
24. HIV infection and age effects on striatal structure are additive.
O'Connor EE; Zeffiro T; Lopez OL; Becker JT; Zeffiro T
J Neurovirol; 2019 Aug; 25(4):480-495. PubMed ID: 31028692
[TBL] [Abstract][Full Text] [Related]
25. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment.
Harezlak J; Buchthal S; Taylor M; Schifitto G; Zhong J; Daar E; Alger J; Singer E; Campbell T; Yiannoutsos C; Cohen R; Navia B;
AIDS; 2011 Mar; 25(5):625-33. PubMed ID: 21297425
[TBL] [Abstract][Full Text] [Related]
26. Case control study: magnetic resonance spectroscopy of brain in HIV infected patients.
Bairwa D; Kumar V; Vyas S; Das BK; Srivastava AK; Pandey RM; Sharma SK; Jagannathan NR; Sinha S
BMC Neurol; 2016 Jul; 16():99. PubMed ID: 27405321
[TBL] [Abstract][Full Text] [Related]
27. Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.
Van Dalen YW; Blokhuis C; Cohen S; Ter Stege JA; Teunissen CE; Kuhle J; Kootstra NA; Scherpbier HJ; Kuijpers TW; Reiss P; Majoie CBLM; Caan MWA; Pajkrt D
Medicine (Baltimore); 2016 Mar; 95(12):e3093. PubMed ID: 27015179
[TBL] [Abstract][Full Text] [Related]
28. CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease.
Anderson AM; Fennema-Notestine C; Umlauf A; Taylor MJ; Clifford DB; Marra CM; Collier AC; Gelman BB; McArthur JC; McCutchan JA; Simpson DM; Morgello S; Grant I; Letendre SL;
J Neurovirol; 2015 Oct; 21(5):559-67. PubMed ID: 26069183
[TBL] [Abstract][Full Text] [Related]
29. Micro-structural brain alterations in aviremic HIV+ patients with minor neurocognitive disorders: a multi-contrast study at high field.
Granziera C; Daducci A; Simioni S; Cavassini M; Roche A; Meskaldji D; Kober T; Metral M; Calmy A; Helms G; Hirschel B; Lazeyras F; Meuli R; Krueger G; Du Pasquier RA
PLoS One; 2013; 8(9):e72547. PubMed ID: 24039777
[TBL] [Abstract][Full Text] [Related]
30. Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy.
Roc AC; Ances BM; Chawla S; Korczykowski M; Wolf RL; Kolson DL; Detre JA; Poptani H
Arch Neurol; 2007 Sep; 64(9):1249-57. PubMed ID: 17620480
[TBL] [Abstract][Full Text] [Related]
31. Neurometabolic Remodeling in Chronic Hiv Infection: a Five-Year Follow-up Multi-Voxel Mrs Study.
Boban J; Thurnher MM; Brkic S; Lendak D; Bugarski Ignjatovic V; Todorovic A; Kozic D
Sci Rep; 2019 Dec; 9(1):19799. PubMed ID: 31875001
[TBL] [Abstract][Full Text] [Related]
32. Cerebral patterns of neuropsychological disturbances in hepatitis C patients.
Prell T; Dirks M; Arvanitis D; Braun D; Peschel T; Worthmann H; Schuppner R; Raab P; Grosskreutz J; Weissenborn K
J Neurovirol; 2019 Apr; 25(2):229-238. PubMed ID: 30610739
[TBL] [Abstract][Full Text] [Related]
33. Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.
Vassallo M; Durant J; Lebrun-Frenay C; Fabre R; Ticchioni M; Andersen S; DeSalvador F; Harvey-Langton A; Dunais B; Cohen-Codar I; Montagne N; Cua E; Fredouille-Heripret L; Laffon M; Cottalorda J; Dellamonica P; Pradier C
HIV Med; 2015 Aug; 16(7):431-40. PubMed ID: 25981452
[TBL] [Abstract][Full Text] [Related]
34. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.
Cohen RA; Harezlak J; Schifitto G; Hana G; Clark U; Gongvatana A; Paul R; Taylor M; Thompson P; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B
J Neurovirol; 2010 Feb; 16(1):25-32. PubMed ID: 20113183
[TBL] [Abstract][Full Text] [Related]
35. Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury.
Yiannoutsos CT; Nakas CT; Navia BA;
Neuroimage; 2008 Mar; 40(1):248-55. PubMed ID: 18191586
[TBL] [Abstract][Full Text] [Related]
36. White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration.
Cysique LA; Soares JR; Geng G; Scarpetta M; Moffat K; Green M; Brew BJ; Henry RG; Rae C
J Neurovirol; 2017 Aug; 23(4):539-547. PubMed ID: 28324319
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal assessment of subcortical gray matter volume, cortical thickness, and white matter integrity in HIV-positive patients.
Corrêa DG; Zimmermann N; Tukamoto G; Doring T; Ventura N; Leite SC; Cabral RF; Fonseca RP; Bahia PR; Gasparetto EL
J Magn Reson Imaging; 2016 Nov; 44(5):1262-1269. PubMed ID: 27079832
[TBL] [Abstract][Full Text] [Related]
38. Effects of age, HIV, and HIV-associated clinical factors on neuropsychological functioning and brain regional volume in HIV+ patients on effective treatment.
Gawron N; Choiński M; Szymańska-Kotwica B; Pluta A; Sobańska M; Egbert AR; Desowska A; Wolak T; Horban A; Firląg-Burkacka E; Bieńkowski P; Sienkiewicz-Jarosz H; Scińska-Bieńkowska A; Biswal B; Rao SM; Bornstein R; Łojek E
J Neurovirol; 2019 Feb; 25(1):9-21. PubMed ID: 30298203
[TBL] [Abstract][Full Text] [Related]
39. Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy.
Perez S; Johnson AM; Xiang SH; Li J; Foley BT; Doyle-Meyers L; Panganiban A; Kaur A; Veazey RS; Wu Y; Ling B
J Neurovirol; 2018 Feb; 24(1):62-74. PubMed ID: 29181724
[TBL] [Abstract][Full Text] [Related]
40. Factors related to HIV-associated neurocognitive impairment differ with age.
Fogel GB; Lamers SL; Levine AJ; Valdes-Sueiras M; McGrath MS; Shapshak P; Singer EJ
J Neurovirol; 2015 Feb; 21(1):56-65. PubMed ID: 25404233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
